OB3 logo

OptiBiotix Health DB:OB3 Stock Report

Last Price

€0.23

Market Cap

€24.0m

7D

-14.6%

1Y

110.8%

Updated

27 Mar, 2024

Data

Company Financials

OB3 Stock Overview

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom.

OB3 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

OptiBiotix Health Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OptiBiotix Health
Historical stock prices
Current Share PriceUK£0.23
52 Week HighUK£0.48
52 Week LowUK£0.064
Beta1.61
1 Month Change-7.14%
3 Month Change-19.31%
1 Year Change110.81%
3 Year Change-60.67%
5 Year Change-74.17%
Change since IPO-73.41%

Recent News & Updates

Recent updates

Shareholder Returns

OB3DE BiotechsDE Market
7D-14.6%2.1%1.9%
1Y110.8%37.0%7.3%

Return vs Industry: OB3 exceeded the German Biotechs industry which returned 37% over the past year.

Return vs Market: OB3 exceeded the German Market which returned 7.3% over the past year.

Price Volatility

Is OB3's price volatile compared to industry and market?
OB3 volatility
OB3 Average Weekly Movement10.7%
Biotechs Industry Average Movement5.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: OB3's share price has been volatile over the past 3 months.

Volatility Over Time: OB3's weekly volatility has decreased from 18% to 11% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20069Stephen O'Harahttps://www.optibiotix.com

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food and beverages.

OptiBiotix Health Plc Fundamentals Summary

How do OptiBiotix Health's earnings and revenue compare to its market cap?
OB3 fundamental statistics
Market cap€23.97m
Earnings (TTM)-€15.36m
Revenue (TTM)€803.05k

29.9x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OB3 income statement (TTM)
RevenueUK£689.00k
Cost of RevenueUK£349.00k
Gross ProfitUK£340.00k
Other ExpensesUK£13.52m
Earnings-UK£13.17m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.13
Gross Margin49.35%
Net Profit Margin-1,912.19%
Debt/Equity Ratio0%

How did OB3 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.